
تعداد نشریات | 20 |
تعداد شمارهها | 1,221 |
تعداد مقالات | 11,153 |
تعداد مشاهده مقاله | 76,715,282 |
تعداد دریافت فایل اصل مقاله | 100,978,559 |
Serum ACE2 and Anti-MMR Antibody Profiles in Pediatric Patients with and without SARS-CoV-2 Infection | ||
Iranian Journal of Immunology | ||
دوره 22، شماره 3، آذر 2025، صفحه 7-7 | ||
نوع مقاله: Original Article | ||
شناسه دیجیتال (DOI): 10.22034/iji.2025.104055.2879 | ||
نویسندگان | ||
Zohre Labbani-Motlagh* 1؛ Zohreh Nozarian2؛ Mohammad Taghi Haghi Ashtiani3؛ Sajjadeh Movahedinia4؛ Mohammad Vasei5؛ Negin Hosseini Rouzbahani6 | ||
1Toxicology Research Center, Aja University of Medical Sciences, Tehran, Iran. | ||
2Department of Molecular Pathology and Cytogenetics, Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran. | ||
3Department of Pathology, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran. | ||
4Department of Molecular Pathology and Cytogenetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. | ||
5Gene Therapy Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. | ||
6Department of Medical Immunology, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran. | ||
چکیده | ||
Background: Coronavirus Disease 2019 (COVID-19) typically manifests with milder symptoms and lower mortality rates in children when compared to adults. Objective: To investigate potential mechanisms underlying this age-related protection, we examined whether serum levels of angiotensin-converting enzyme 2 (ACE2) and IgG antibody titers against Measles, Mumps, and Rubella (MMR) vaccines are associated with susceptibility to SARS-CoV-2 infection in the pediatric population. Methods: In this case-control study, conducted before the introduction of mass COVID-19 vaccination, we enrolled children aged 1–15 years. The cases were hospitalized children with confirmed COVID-19, while the control group consisted of outpatients with non-infectious, non-immunodeficient conditions and no documented history of COVID-19. The COVID-19 status was confirmed using RT-PCR. Serum levels of ACE2 and anti-MMR IgG antibodies were assessed using ELISA. Results: Eighty-three patients including 39 cases with COVID-19 infection and 44 controls were enrolled in this study. The median serum ACE2 levels were 3.6 in COVID-19 cases and 3.8 ng/mL in control cases (P=0.440). Similarly, antibody levels against Mumps (P=0.788), Measles (P=0.281), and Rubella (P=0.083) did not differ significantly between the groups, although Rubella seropositivity was more frequent in COVID-19 cases than in controls (P=0.039). Conclusions: Our findings did not support a significant association between serum ACE2 levels or MMR antibody titers and protection against COVID-19 in children. The higher prevalence of Rubella seropositivity among infected cases may suggest possible cross-reactivity, but causal relationships could not be established in this study. | ||
کلیدواژهها | ||
ACE2؛ COVID-19؛ Measles؛ MMR vaccine؛ Mumps؛ Rubella؛ SARS-CoV-2 | ||
آمار تعداد مشاهده مقاله: 9 |